SCHEMBL19080015

SCHEMBL19080015

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5oc6ccc7ccccc7c6c5c5ccccc45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.47
AHR P35869 3/20 0.47
PAX8 Q06710 2/20 0.47
CYP1A1 P04798 1/20 0.47
CYP1A2 P05177 1/20 0.47
FYN P06241 1/20 0.47
MAPK3 P27361 1/20 0.47
KDM4E B2RXH2 4/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
TDP1 Q9NUW8 3/20 0.37
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127329 0.93 ABCG2 (0.50) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL20127737 0.90 ABCG2 (0.48) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL20127332 0.90 ABCG2 (0.48) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19080078 0.89 ABCG2 (0.39) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19079932 0.88 ABCG2 (0.49) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19080045 0.88 AHR (0.42) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL22541904 0.87 ABCG2 (0.43) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19076393 0.87 CA1 (0.38) ABCG2AHRKDM4EKMT2AMEN1
SCHEMBL22541863 0.86 ABCG2 (0.43) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19080017 0.85 CYP1A1 (0.44) ABCG2AHRPAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ABCG2 4758/4885AHR 2211/4885PAX8 1759/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ABCG2 4758/4885AHR 2211/4885PAX8 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.